Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer

Annals of Oncology

Volumn 21, Issue 6, 2009, Pages 1285-1289

  Park, J S ^a   Kim, H K ^a   Choi, Y S ^a   Kim, K ^a   Shim, Y M ^a   Jo, J ^b   Lee, W Y ^a   Chun, H K ^a   Park, Y S ^a   Kang, W K ^a   Kim, J ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Colorectal cancer; Pulmonary metastasis; Repeated metastasectomy

Indexed keywords

IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG METASTASIS; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASECTOMY; MORBIDITY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; SURGICAL TECHNIQUE; AGED; CARCINOMA; COLORECTAL NEOPLASMS; EVALUATION STUDY; FOLLOW UP; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PERIODICITY; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; STATISTICS AND NUMERICAL DATA; SURVIVAL; TREATMENT OUTCOME;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIODICITY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77953998171     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp475     Document Type: Article

References (22)

1. Pastorino U, Buyse M, Friedel G et al. Long-term results of lung metastasectomy: prognostic analysis based on 5206 cases. J Thorac Cardiovasc Surg 1997; 113: 37-49.
2. Rusch VW. Pulmonary metastasectomy. Current indications. Chest 1995; 107 (6 Suppl): 322S-331S.
3. Welter S, Jacobs J, Krbek T et al. Long-term survival after repeated resection of pulmonary metastases from colorectal cancer. Ann Thorac Surg 2007; 84(1): 203-210.
4. Saito Y, Omiya H, Kohno K et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002; 124(5): 1007-1013.
5. Kandioler D, Krömer E, Tüchler H et al. Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg 1998; 65(4): 909-912.
6. Groeger AM, Kandioler D, Mueller MR et al. Survival after surgical treatment of recurrent pulmonary metastases. Eur J Cardiothorac Surg 1997; 12(5): 703-705.
7. Desch CE, Benson AB III, Somerfield MR. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23: 8512-8519.
8. Chau I, Allen MJ, Cunningham D. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004; 22: 1420-1429.
9. Lee WS, Yun SH, Chun HK et al. Clinical usefulness of chest radiography in detection of pulmonary metastases after curative resection for colorectal cancer. World J Surg 2007; 31(7): 1502-1506.
10. Huguet EL, Old S, Praseedom RK et al. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Hepatogastroenterology 2007; 54(78): 1667-1671.
11. Reinhardt MJ, Wiethoelter N, Matthies A et al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging 2006; 33(2): 134-139.
12. Lee F, Jung KH, Park YS et al. Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. Cancer Chemother Pharmacol 2009; 64(4): 657-663.
13. Kim K, Nam E, Lee NS et al. Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer. Am J Clin Oncol 2002; 25(4): 354-357.
14. Pfannschmidt J, Muley T, Hoffmann H et al. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg 2003; 126(3): 732-739.
15. Iizasa T, Suzuki M, Yoshida S et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 2006; 82(1): 254-260.
16. Koga R, Yamamoto J, Saiura A et al. Surgical resection of pulmonary metastases from colorectal cancer: four favourable prognostic factors. Jpn J Clin Oncol 2006; 36(10): 643-648.
17. Vogelsang H, Haas S, Hierholzer C et al. Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 2004; 91(8): 1066-1071.
18. Poncelet AJ, Lurquin A, Weynand B et al. Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience. Eur J Cardiothorac Surg 2007; 31(2): 173-180.
19. Van Geel AN, Hoekstra HJ, van Coevorden F et al. Repeated resection of recurrent pulmonary metastatic soft tissue sarcoma. Eur J Surg Oncol 1994; 20(4): 436-440.
20. Piltz S, Meimarakis G, Wichmann MW et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002; 73(4): 1082-1087.
21. Marulli G, Sartori F, Bassi PF et al. Long-term results of surgical management of pulmonary metastases from renal cell carcinoma. Thorac Cardiovasc Surg 2006; 54(8): 544-547.
22. Nakajima J, Tanaka M, Matsumoto J et al. Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma. World J Surg 2005; 29(6): 715-718.